📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. (2017)

First Author: West NR

Attributed to: The Oxford Protein Production Facility-UK funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nm0617-788d

PubMed Identifier: 28586341

Publication URI: http://europepmc.org/abstract/MED/28586341

Type: Journal Article/Review

Volume: 23

Parent Publication: Nature medicine

Issue: 6

ISSN: 1078-8956